Latest Breaking News On - Yuanfang li - Page 1 : vimarsana.com

A new analysis found that relapse-free survival is a poor surrogate endpoint for overall survival in adjuvant immunotherapy trials in a variety of cancer types.

Yuanfang liJournal of the national cancer instituteNational natural science foundation of chinaSun yat sen university cancer centerNational cancerNational natural science foundationBiologic therapyAlignant neoplasiaLung cancerUng carcinomaAncer lungSmall cell lung cancerSkin cancerAlignant skin neoplasmMalignant kidney neoplasmKidney cancer